
A comprehensive analysis of the global GLP-1 receptor agonists market—exploring cutting-edge product innovation, expanding therapeutic and metabolic health applications, evolving supply chain dynamics, and the strategic outlook for pharmaceutical manufacturers and ingredient suppliers navigating the future of obesity management and metabolic disease treatment.